379 related articles for article (PubMed ID: 29332586)
21. New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents.
Roldán-Peña JM; Alejandre-Ramos D; López Ó; Maya I; Lagunes I; Padrón JM; Peña-Altamira LE; Bartolini M; Monti B; Bolognesi ML; Fernández-Bolaños JG
Eur J Med Chem; 2017 Sep; 138():761-773. PubMed ID: 28728108
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic Potential of Multifunctional Tacrine Analogues.
Przybyłowska M; Kowalski S; Dzierzbicka K; Inkielewicz-Stepniak I
Curr Neuropharmacol; 2019; 17(5):472-490. PubMed ID: 29651948
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Chen Y; Zhu J; Mo J; Yang H; Jiang X; Lin H; Gu K; Pei Y; Wu L; Tan R; Hou J; Chen J; Lv Y; Bian Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):290-302. PubMed ID: 29278947
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids.
Huang L; Su T; Shan W; Luo Z; Sun Y; He F; Li X
Bioorg Med Chem; 2012 May; 20(9):3038-48. PubMed ID: 22472046
[TBL] [Abstract][Full Text] [Related]
25. Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer's disease.
Bartolini M; Pistolozzi M; Andrisano V; Egea J; López MG; Iriepa I; Moraleda I; Gálvez E; Marco-Contelles J; Samadi A
ChemMedChem; 2011 Nov; 6(11):1990-7. PubMed ID: 21990269
[No Abstract] [Full Text] [Related]
26. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
[TBL] [Abstract][Full Text] [Related]
27. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
Li SY; Wang XB; Xie SS; Jiang N; Wang KD; Yao HQ; Sun HB; Kong LY
Eur J Med Chem; 2013 Nov; 69():632-46. PubMed ID: 24095756
[TBL] [Abstract][Full Text] [Related]
28. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of novel tacrine-indole hybrids as potential multitarget-directed ligands for the treatment of Alzheimer's disease.
Hamulakova S; Kudlickova Z; Janovec L; Mezencev R; Deckner ZJ; Chernoff YO; Janockova J; Ihnatova V; Bzonek P; Novakova N; Hepnarova V; Hrabinova M; Jun D; Korabecny J; Soukup O; Kuca K
Future Med Chem; 2021 May; 13(9):785-804. PubMed ID: 33829876
[TBL] [Abstract][Full Text] [Related]
30. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease.
Uliassi E; Bergamini C; Rizzardi N; Naldi M; Cores Á; Bartolini M; Carlos Menéndez J; Bolognesi ML
Bioorg Med Chem; 2023 Aug; 91():117419. PubMed ID: 37487339
[TBL] [Abstract][Full Text] [Related]
31. Tacrine derivatives and Alzheimer's disease.
Tumiatti V; Minarini A; Bolognesi ML; Milelli A; Rosini M; Melchiorre C
Curr Med Chem; 2010; 17(17):1825-38. PubMed ID: 20345341
[TBL] [Abstract][Full Text] [Related]
32. Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy.
Boulebd H; Ismaili L; Bartolini M; Bouraiou A; Andrisano V; Martin H; Bonet A; Moraleda I; Iriepa I; Chioua M; Belfaitah A; Marco-Contelles J
Molecules; 2016 Mar; 21(4):400. PubMed ID: 27023499
[TBL] [Abstract][Full Text] [Related]
33. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
[TBL] [Abstract][Full Text] [Related]
34. Novel multipotent phenylthiazole-tacrine hybrids for the inhibition of cholinesterase activity, β-amyloid aggregation and Ca²⁺ overload.
Wang Y; Wang F; Yu JP; Jiang FC; Guan XL; Wang CM; Li L; Cao H; Li MX; Chen JG
Bioorg Med Chem; 2012 Nov; 20(21):6513-22. PubMed ID: 23000296
[TBL] [Abstract][Full Text] [Related]
35. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
[TBL] [Abstract][Full Text] [Related]
36. Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.
Huang L; Miao H; Sun Y; Meng F; Li X
Eur J Med Chem; 2014 Nov; 87():429-39. PubMed ID: 25282266
[TBL] [Abstract][Full Text] [Related]
37. Nontoxic and neuroprotective β-naphthotacrines for Alzheimer's disease.
Esquivias-Pérez M; Maalej E; Romero A; Chabchoub F; Samadi A; Marco-Contelles J; Oset-Gasque MJ
Chem Res Toxicol; 2013 Jun; 26(6):986-92. PubMed ID: 23676090
[TBL] [Abstract][Full Text] [Related]
38. Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines.
de Los Ríos C; Marco-Contelles J
Eur J Med Chem; 2019 Mar; 166():381-389. PubMed ID: 30739821
[TBL] [Abstract][Full Text] [Related]
39. New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer's Disease.
Rajeshwari R; Chand K; Candeias E; Cardoso SM; Chaves S; Santos MA
Molecules; 2019 Feb; 24(3):. PubMed ID: 30736397
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD.
Digiacomo M; Chen Z; Wang S; Lapucci A; Macchia M; Yang X; Chu J; Han Y; Pi R; Rapposelli S
Bioorg Med Chem Lett; 2015 Feb; 25(4):807-10. PubMed ID: 25597007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
